InhaleRx is considering making its inhaled THC medicine available through the Special Access Scheme (SAS) as […]
InhaleRx weighs Special Access Scheme launch while targeting big pharma partnership
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Breakthrough cancer pain
BTcP
Darryl Davies
Dr Sud Agarwal
Drug registration
FDA
InhaleRx
IRX211
IRX616a
panic disorder
Sean Williams
Related Articles
